Leukemia, Lymphoid clinical trials
The registry lists 1,783 studies for Leukemia, Lymphoid across more than 10 countries. 178 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.
Status
- Completed
- 973
- Terminated
- 285
- Status unknown
- 194
- Recruiting
- 138
- Withdrawn
- 103
- Not yet recruiting
- 38
Phase
- Phase 2
- 822
- Phase 1
- 603
- Phase 3
- 155
- Phase 4
- 48
- Early Phase 1
- 29
Where
- United States
- 966
- China
- 186
- Italy
- 152
- Germany
- 137
- France
- 134
- Canada
- 127
Who runs them
National Cancer Institute (NCI) (98) · M.D. Anderson Cancer Center (98) · Fred Hutchinson Cancer Center (49) · Children's Oncology Group (48) · Hoffmann-La Roche (32) · Gruppo Italiano Malattie EMatologiche dell'Adulto (32) · Novartis Pharmaceuticals (29) · St. Jude Children's Research Hospital (27)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,783 — search for more.
- A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)RecruitingNCT05254743Phase 323 countries
- Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRDRecruitingNCT07566364Phase 21 country
- Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant LeukemiaRecruitingNCT06516679Phase 21 country
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 21 country
- Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable1 country
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeRecruitingNCT03670966Phase 1/21 country
- Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available ImmunotherapyRecruitingNCT058653011 country
- A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.RecruitingNCT03219450Phase 11 country
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)RecruitingNCT03970096Phase 21 country
- Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)RecruitingNCT06785324Not applicable1 country
- National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic LeukemiaRecruitingNCT070197661 country
- Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"RecruitingNCT07021677Phase 21 country
- Time Restricted Eating in Haematological MalignanciesNot yet recruitingNCT06862323Phase 21 country
- Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid MutationsRecruitingNCT07012447Phase 21 country
- Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte MalignanciesRecruitingNCT055413411 country
- Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center StudyNot yet recruitingNCT07003464Phase 21 country
- A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLRecruitingNCT06547528Phase 11 country
- Intravenous Autologous CD19 CAR-T Cells for R/R B-ALLRecruitingNCT03937544Phase 2/31 country
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1RecruitingNCT06718244Phase 21 country
- Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic LeukemiaRecruitingNCT06034561Phase 21 country
- Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilRecruitingNCT059597201 country
- KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT ChildrenEnrolling by invitationNCT02646839Phase 21 country
- The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLRecruitingNCT03509961Phase 21 country
- Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCTRecruitingNCT06061094Phase 21 country
- Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"RecruitingNCT04920968Phase 21 country
- Study of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLLRecruitingNCT04494503Phase 1/21 country
- Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)RecruitingNCT06462365Phase 11 country
- AGMT Austrian CLL (Chronic Lymphocytic Leukemia) RegistryRecruitingNCT062504651 country
- Hepatoprotective for Children and Adolescent With Acute Lymphoblastic LeukemiaRecruitingNCT06918054Phase 41 country
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingNCT03643276Phase 38 countries
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with LeukemiaEnrolling by invitationNCT06560879Phase 21 country
- Study on the Diagnosis and Management of CLL in Italy by GIMEMARecruitingNCT048679151 country
- Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06581081Not applicable1 country
- Raman Spectroscopy Compared to Flow CytometryRecruitingNCT062914281 country
- CD-19 CAR-T Cell for Pediatric ALL or LymphomaRecruitingNCT06866873Not applicable1 country
- Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCTNot yet recruitingNCT06861348Phase 21 country
- Thiotepa, Cyclophosphamide, Clarithromycin and CytarabineRecruitingNCT06060782Phase 11 country
- A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing SettingRecruitingNCT067886391 country
- Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia PatientsNot yet recruitingNCT06654206Early Phase 1
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06557161Phase 21 country
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06564493Phase 21 country
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06559345Phase 21 country
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06564545Phase 21 country
- Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID ProjectRecruitingNCT068218802 countries
- Effects of Core Stabilization Exercises in Children with Acute Lymphoblastic LeukemiaRecruitingNCT06794762Not applicable1 country
- Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06793241Early Phase 11 country
- The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic LeukemiaRecruitingNCT06307600Early Phase 11 country
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1Not yet recruitingNCT06777264Phase 2
- CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLRecruitingNCT06179524Phase 21 country
- Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic LeukemiaRecruitingNCT05281809Phase 21 country